Therapeutic effects of dyhidroartemisinin piperaquine versus chloroquine for uncomplicated Vivax Malaria in Kupang, East Nusa Tenggara, Indonesia

International Journal of Pharmaceutical Sciences Review and Research

Volumn 31, Issue 2, 2015, Pages 247-251

  Lidia, Kartini ^a   Dwiprahasto, Iwan ^b   Kristin, Erna ^b  

^a Nusa Cendana University   (Indonesia)

^b GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

Chloroquine; Clinical response; Dihydroartemisinin piperaquine; Parasitological response

Indexed keywords

CHLOROQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; PRIMAQUINE;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; PARASITE LOAD; PARASITEMIA; PATHOGEN CLEARANCE; PLASMODIUM VIVAX MALARIA; QUASI EXPERIMENTAL STUDY; TREATMENT OUTCOME;

EID: 84928191799     PISSN: 0976044X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. World Health Organization. World Malaria Report 2010. Geneva: WHO, 2010.
2. Ministry of Health of Republic Indonesia. Epidemiologi malaria in Indonesia. Buletin Jendela Data dan Informasi Kesehatan, 1, 2011, 1-2.
3. Ministry of Health of East Nusa Tenggara Province. Data detection of malaria cases in 2010. Kupang: Ministry of Health East Nusa Tenggara Province, 2010.
4. World Health Organization. WHO Global Report on anti malarial drug efficacy and drug resistance 2000-2010. Geneva: WHO, 2010.
5. World Health Organization. WHO Guidelines for the Treatment of Malaria. 2nded. Geneva: WHO, 2010.
6. Ministry of Health of Republic of Indonesia. Guidelines for the management of malaria cases in Indonesia. Jakarta: Director General of Disease Control and Environmental Health, Ministry of Health of Indonesia, 2008.
7. Kusriastuti R, Surya A. New treatment policy of malaria as a part of malaria control program in Indonesia Indones J Intern Med, 44(3), 2012, 265-269.
8. Harijanto PN. ACT sebagai pilihan obat malaria ringan di Indonesia. Cermin Dunia Kedokteran, 38(2), 2011, 112-114.
9. Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet, 369, 2007, 757-765.
10. Sutanto I, Suprijanto S, Nurhayati, Manoempil P, Baird JK. Resistance to Chloroquine by Plasmodium vivax at Alor in the Lesser Sundas Archipelago in Eastern Indonesia. Am J Trop Med Hyg, 81(2), 2009, 338-342.
11. Ministry of Health Republic of Indonesia. Appendix Minister of Health Regulation No. 5 of 2013 on Guidelines for Management of Malaria. Jakarta: Ministry of Health Republic of Indonesia, 2013.
12. Setiawan B. Current Malaria Management: Guideline 2009. Indones J Intern Med, 42(4), 2010, 258-261.
13. World Health Organization. Methods for Surveillance of Antimalarial Drug Efficacy. Geneva: WHO, 2009.
14. Baird JK. Resistance to therapies for infection by plasmodium vivax. Clin Microbiol Rev, 22(3), 2009, 508-534.
15. Thanh NX, Trung TN, Phong NC, Quang HH, Dai B, Shanks GD. The efficacy and tolerability of artemisin in piperaquine (ArtequickW) versus artesunate amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam. Malar J, 11, 2012, 217.
16. Ritter JM, Lewis LD, Mant TG, Ferro A. Clinical Pharmacology and Therapeutics. 5th ed. London: Hodder Arnold part of Hachette Livre UK, 2008.
17. Moore BR, Page-Sharp M, Stoney JR, Ilett KF, Jago JD, Batty KT. Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model. Antimicrob Agents Chemother, 55(8), 2011, 3899-3907.
18. Chinh NT, Quang NN, Thanh NX, Dai B, Geue JP, Addison RS. Pharmacokinetics and bioequivalence evaluation of two fixed-dose tablet formulations of dihydroartemisinin and piperaquine in Vietnamese subjects. Antimicrob Agents Chemother, 53(2), 2009: 828-831.
19. Anstey NM, Russell B, Yeo TW, Price RN. The pathophysiology of vivax malaria. Trends Parasitol, 25(5), 2009, 220-227.
20. Robinson LJ, D'Ombrain MC, Stanisic DI, Taraika J, Bernard N, Richards JS. Cellular Tumor Necrosis Factor, Gamma Interferon, and Interleukin-6 Responses as Correlates of Immunity and Risk of Clinical Plasmodium falciparum Malaria in Children from Papua New Guinea. Infect Immun, 2009, 3033-3043.
21. Awab GR, Pukrittayakamee S, Imwong M, Dondorp AM, Woodrow CJ, Sue JL. Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority trial. Malar J, 9, 2010, 105.
22. Poravuth Y, Socheat D, Rueangweerayut R, Uthaisin C, Phyo AP, Valecha N. Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax Malaria: A randomized, double-blind, non-inferiority trial, English. PLoS One, 6(1), 2011, e14501.
23. Taylor WRJ, Widjaja H, Richie TL, Basri H, Ohrt C, Tjitra E. Chloroquine/Doxycycline Combination Versus Chloroquine Alone And Doxycycline Alone For The Treatment Of Plasmodium Falciparum And Plasmodium Vivax Malaria In Northeastern Irian Jaya Indonesia. Am J Trop Med Hyg, 64(5), 2001, 223-228.
24. Tjitra E, Maladi, Prasetyorini B, Suprianto S, Harun S, Nurhayati. Efficacy of chloroquine, chloroquine plus sulphadoxine-pyrimethamine, and amodiaquine for treatment of vivax malaria in Bangka island, Indonesia: a randomized trial. Med J Indon, 17, 2008, 96-106.
25. Siswantoro H, Ratcliff A, Kenangalem E, Wuwung M, Maristela R, Rumaseuw R. Efficacy of existing antimalarial drugs for uncomplicated malaria in Timika Papua Indonesia. Med J Indones. 15, 2006, 251-258.
26. Hasugian AR, Purba HL, Kenangalem E, Wuwung RM, Ebsworth EP, Maristela R. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and post treatment prophylaxis against multidrug-resistant Plasmodium falciparum and plasmodium vivax malaria. Clin Infect Dis, 44, 2007, 1067-1074.
27. Hasugian AR, Risniati Y, Tjitra E, Siswantoro H, Avrina R, Delima. Efficacy and afety dihydroartemisinin piperaquine in patients with Plasmodium vivax in Kalimantan and Sulawesi. Media Litbang Kesehatan, 22(2), 2012, 78-86.
28. Sutanto I, Endawati D, Liem HL, Laihad F, Setiabudy R, Baird JK. Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra western Indonesia. Malar J, 9, 2010, 52.